APA (7th ed.) Citation

Ho, W. L., Wong, H., & Yau, T. (2013). The ophthalmological complications of targeted agents in cancer therapy: What do we need to know as ophthalmologists? Acta Ophthalmologica (1755375X), 91(7), 604. https://doi.org/10.1111/j.1755-3768.2012.02518.x

Chicago Style (17th ed.) Citation

Ho, Wing L., Hilda Wong, and Thomas Yau. "The Ophthalmological Complications of Targeted Agents in Cancer Therapy: What Do We Need to Know as Ophthalmologists?" Acta Ophthalmologica (1755375X) 91, no. 7 (2013): 604. https://doi.org/10.1111/j.1755-3768.2012.02518.x.

MLA (9th ed.) Citation

Ho, Wing L., et al. "The Ophthalmological Complications of Targeted Agents in Cancer Therapy: What Do We Need to Know as Ophthalmologists?" Acta Ophthalmologica (1755375X), vol. 91, no. 7, 2013, p. 604, https://doi.org/10.1111/j.1755-3768.2012.02518.x.